Jeffrey Stevens, the CEO and co-founder of Psyched Wellness PSYCF, has bought 321,000 shares of the company in the open market at CA$0.125 per share for a total cost of of CA$40,125 (around $31,750).
“Our stock price has increased in the last quarter alone. In addition to our market growth, we have experienced a number of recent successes that have strengthened our position and are excited to be approved to launch our flagship product, Calm, in the U.S.," Stevens said.
The psychedelics exec is speaking later Tuesday at the inaugural Benzinga Psychedelics Capital Conference.
"Our stock price doesn't reflect this growth yet, but it will. We have been working diligently to position and grow our business, and I believe that we are on track to deliver sustainable, long-term shareholder value.”
PSYCF Price Action: Psyched Wellness shares were trading 2.22% higher at $0.092 late Tuesday morning.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.